Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This clinical trial is designed to evaluate the efficacy of single immediate intravesical chemotherapy instillation in the prevention of bladder recurrence after nephroureterectomy for primary upper tract urothelial carcinoma (UTUC) patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking University First Hospital
• Treatments: Pirarubicin

Criteria

Inclusion Criteria:

• Suspected UTUC patients without history of bladder tumor.

• Suspected UTUC patients without synchronous bladder tumor.

• Suspected UTUC patients without contralateral UTUCs.

Exclusion Criteria:

• Patients with history of bladder tumor.

• Patients with synchronous bladder tumor.

• Patients with contralateral UTUCs.

• Patients with advanced stage (T4).

• Patients with other malignant tumors.